| |
Agriculture & Microenterprise Development
Kenya
Agricultural Biotechnology Support Program
Background
The purposes of the Kenya Agricultural Biotechnology Support Program
(KABSP) over the current 5-year strategic period are: a) to
apply biotechnology to develop improved varieties of crops and improved
animal production; b) Build capacity in biotechnology in Kenya;
c) increase public knowledge and awareness in biotechnology; and
d) build a functional National Biosafety Framework. The intended
inputs to the program include provision of technical assistance,
training, and commodities to support research in biotechnology,
development of a biosafety regulatory framework and increased public
awareness and outreach.
The planned activities include: a) genetic engineering of sweet
potatoes with genes for resistance to the sweet potato feathery
mottle virus (SPFMV) and sweet potato weevil (Cylas formicarius);
b) search for genes for resistance to large grain borer (Prostephenus
truncatus) and maize weevil (Sitophilus zeamais), develop protocols
for genetic transformation of local maize varieties, transform the
varieties with identified genes for resistance to maize storage
pests, train two scientists in genetic transformation of maize c)
research in development, evaluation, and commercialization of diagnostics
for eight animal disease including Contagious bovine pleuropnuemonia
(CBPP), Contagious caprine pleuropnuemonia (CCPP), Newcastle (NC),
Nairobi sheep disease (NSD), Rift Valley Fever (RVF), lumpy skin
disease (LSD), heartwater (HW) and Foot and Mouth disease (FMD)
and vaccines for RVF and CBPP diseases; d) rehabilitation of a biotechnology
facility at the Kenya Agricultural Research Institute (KARI); e)
improve public knowledge and awareness in biotechnology: among consumers,
private sector, parliamentarians and media personnel in biotechnology
related issues; and g) strengthen the biotechnology
regulatory framework by organizing the national biosafety regulatory
system through training, upgrading of current regulatory mandates
to cover biotechnology, memorandums of understanding, facilitation
of development of national policy and law in biotechnology.
The expected outputs include a) sweet potato varieties resistant
to sweet potato feathery mottle viruses developed and commercialized;
b) maize varieties resistant to maize weevil and the large
grain borer developed; c) animal disease diagnostics and vaccines
developed and commercialized; d) increased public knowledge and
awareness in biotechnology increased; e) efficient biosafety regulatory
system with offices for receiving notifications, specific uses such
as feed, food, release into the environment; administrative system
to examine the dossier, a system to audit or perform risk assessment,
a system to allow public and stakeholder comments, a system for
evaluating the risk assessment and/or audit report; f) local capacity
in biotechnology in the above including 6 PhDs and 9 MSc in recombinant
DNA technology; and g) Increased science-based knowledge in biotechnology
in Kenya at farmer, researcher, consumer, general public and government
levels.
Implementing Partners and Progress to date
KARI is collaborating with Donald Danforth Plant Center (USA), Monsanto
Co (USA) and Kenyatta University (Kenya) in development of sweet
potatoes resistant to SPFMV. KARI is further working in collaboration
with CIMMYT and Kenyatta University in development of local maize
varieties resistant to two storage pests. KARI is also collaborating
with International Livestock Research Institute (ILRI) in research
in the development of animal disease diagnostics and vaccines. The
African Biotechnology Stakeholders Forum (ABSF) is collaborating
with Tuskegee University USA) in creating public awareness and knowledge
in biotechnology and related issues. Several governments of
Kenya Ministries (Ministries of Agriculture, Livestock, Trade and
Industry, Health, Constitution, and agencies (such as Kenya
Plant Inspectorate Service, (KEPHIS) from MoA) are working under
the auspices of the National Council of Science and Technology (from
the Ministry of Education Science and Technology) in “Building
a functional National Biosafety National Framework. NCST working
under the aegis of the National Biosafety Committee (NBC) will liaison
with USAID Program for Biosafety Systems (PBS) in implementing pertinent
activities.
Development of Transgenic Sweet potato
Experiments to optimize regeneration protocol for seven
local cultivars of sweet potatoes were incepted but are yet to be
completed. Transformation experiments have been initiated in local
popular variety KSP 36 in addition to CPT 560 using four gene constructs
(pMON54928, pMON54929, pMON54936 and 10575 GUS) donated by Monsanto
Company (Figure 1). Optimizations of protocols for transformation
of KSP 36 with GUS gene are also ongoing). Challenge of four locally
developed transgenic lines and four Monsanto transgenic lines with
SPFMV strains is ongoing at KARI. A survey has been conducted to
collect SPFMV strains from Kakamega, Kisii, Katumani. The
coat protein gene will be sequenced and used to determine variability
within the strains.
Figure1. Transgenic sweet potatoes in greenhouse at KARI National
Agricultural Research laboratories
Four MSc graduates students are being trained at Kenyatta University
to carry of the above experiments
Development of Transgenic Maize resistant to storage pests
The purpose of the activity is to identify genes for resistance
to the maize weevil and the larger grain borer and transform local
lines of maize. To date pertinent stakeholders have been identified
and consulted, the maize hybrid lines for transformation have been
obtained including sites for raising maize embryos.
Development of animal disease vaccines and diagnostic protocols
KARI and other partners plan to develop rapid and accurate disease
diagnostic procedures CBPP, CCPP, NSD, RVFV, LSD, HW) and FMD and
vaccines for RVF and CBPP diseases of livestock. Diagnostic ability
of CBPP is being validated, while protocols for CCPP, NC, LSD, HW
have been incepted. Work on evaluation of Recombinant capripoxvirus/RVF
vaccine has started. The program plans to train three MSc. graduates
with research thesis in disease diagnostics.
Public Awareness in Biotechnology
The overall goal of this activity is to create public awareness
in biotechnology among farmers, consumers, private sector, journalists,
education institutions and parliamentarians. Two communication conferences
have been held for parliamentarians with the aim of goal of creating
general understanding of biotechnology, discussing the Biotechnology
Policy and Biosafety Bill. The first meeting was attended by 30
Mps, while the second one was attended by 69 MPs. The MPs were very
receptive to biotechnology provided it benefited the Society. They
suggested that the biosafety bill should be expounded to cover the
whole scope of biotechnology from research to commercialization
highlighting benefits, potential risks and monitoring and mitigation
measures. The last Conference at Whitesands Hotel in Mombasa was
attended by 80 participants of whom 69 were parliamentarians (Figure
2). All the parliamentarians felt that Kenya needed biotechnology
to spur economic development. Out of 68 members of parliament
representing about 32% of the national constituents 25%, 22.5%,
17.5%, 17.5% and 17.5% felt that biotechnology could benefit their
respective constituents by contributing to the development of agriculture,
health, industry, enhanced trade and environmental management, respectively.
60% were of the opinion that the policy and bill required extensive
amendments to incorporate all the suggestions made during the workshop
and should include particularly, aspects on biotechnology development,
biotechnology adoption and transfer, biosafety, confidentiality
and protection of local germplasm and farmers. 60% of parliamentarians
felt that Kenya should endorse and embrace biotechnology by the
year 2004. This was very encouraging response as it is a direct
indication of their readiness to support the bill with the suggested
amendments as soon as it is presented in parliament.
Figure 2. Hon George Munyasa Khaniri Assistant Minister for Agriculture
and Rural Development giving an Opening Speech during the MPs Biotechnology
Conference at Whitesands Hotel Mombasa
Biosafety Regulatory Framework
The workplan for the Biosafety Regulatory Framework is near completion.
The lead institution will be The National Council of Science and
Technology which will collaborate with the Program for Biosafety
Systems (PBS) to implement several activities that will include
training regulatory stakeholder in examination of applications,
monitoring and inspection, establishment of a national biosafety
secretariat; definition and allocation of regulatory roles to potential
stakeholders including the Ministries of Agriculture and Rural Development,
Health, Education Science and Technology, Environment, Natural Resources
and Wildlife, Industry and Trade
Projected Highlights for 2004
The major outstanding outputs in 2004 will include the enactment
of the Kenya Biosafety Bill, The training of staff from the National
Biosafety Committee in examination of application.
<<Back to list of Program Activities>>
|